Cutaneous chronic graft-versus-host disease (cGVHD) is associated with morbidity, mortality, and impaired quality of life after hematopoietic stem cell transplantation. The clinical features of cutaneous cGVHD are heterogeneous but can be broadly classified into nonsclerotic or sclerotic presentations. This review provides an overview of clinical presentation, diagnosis and differential diagnosis, grading, and treatment of cutaneous cGVHD. Particular attention is given to cutaneous cGVHD in skin of color, which can have unique features and is generally underrepresented in the literature leading to delays in diagnosis. Finally, an overview of long-term skin care for patients with cutaneous cGVHD is provided in order to support patients from a dermatologic perspective as they recover from cGVHD. Multidisciplinary care with frequent communication between transplant specialists and dermatologists is critical to effectively managing cutaneous cGVHD.
Gastric antral vascular ectasia (GAVE) or ‘watermelon stomach’ is a rare angio-dysplastic disorder causing gastric bleeding. The aetiology of GAVE is unknown, but it is associated with several conditions including autoimmune disease, chronic renal failure and liver disorders. It can also develop as a complication of haematopoietic stem cell transplantation (HSCT)-GAVE, most associated with conditioning regimens including busulfan. HSCT-GAVE has also been linked with thrombotic microangiopathy and graft versus host disease (GVHD), but the relationship is poorly understood. This report presents a patient status post-allogeneic HSCT who developed severe refractory GAVE, ultimately found to be a manifestation of liver GVHD responsive to treatment with ruxolitinib.